Fig. 5.
Models for pro-BMP9 structures and binding to receptors. Models for the open-armed, nonlatent pro-BMP9 conformation characterized here (1), the proposed (dashed lines) pro-TGF-β1–like cross-armed conformation of pro-BMP9 (2), and stepwise binding (18) to type I (3) and type II receptors (4).